IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equity Through early,

Related Keywords

Texas ,United States ,Israel ,Sharon Levkoviz ,Oded Bashan ,Lynn Eschenbacher Pharm ,Rosh Pina ,Lynn Eschenbacher ,Indiana University ,Duke University ,Exchange Commission ,University Of Texas At Austin ,Us Congress ,Duke University Health System ,National Pressure Injury Advisory Council ,Drug Administration ,Founder Of Echelon Health Strategies ,Strategic Advisory Board Member At Atlas Health ,Lynn Eschenbacher Pharmd ,Echelon Health Strategies ,Venture Partner ,Chief Customer Officer ,Strategic Advisory Board Member ,Atlas Health ,Chief Pharmacy Officer ,Vice President Medication Management ,Ascension Healthcare ,Medication Safety Officer ,Duke University Health ,Advisory Board ,National Pressure Injury Advisory ,Harbor Statement ,Private Securities Litigation Reform Act ,Chief Financial ,Air Med ,Appoints ,Dr ,Flynn ,Eschenbacher ,To ,Its ,Advisory ,Board ,Gas ,Company ,Advances ,Toward ,Launch ,Of ,Pressuresafe ,Wound ,Care ,Device ,